a pharmaceutical composition used as an anti - inflammatory is prepared . the composition comprises a plasma fraction separated from blood plasma and / or in combination with a pharmaceutical carrier . in a preferred method , the plasma fraction is separated from the blood plasma by mixing with from 3 % to 10 % by weight of the plasma fraction of silica and thereafter centrifuging to allow the plasma fraction to be precipitated out in conjunction with the silica . they are thereafter separated .